Journal articles on the topic 'Cervix uteri Cancer Victoria Prevention'
To see the other types of publications on this topic, follow the link: Cervix uteri Cancer Victoria Prevention.
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 20 journal articles for your research on the topic 'Cervix uteri Cancer Victoria Prevention.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
1
Vasilj, Ivan, Semra Cavaljuga, Marija Strnad, and Ariana Znaor. "Endometrial cancer epidemiology and prevention in Federation of Bosnia and Herzegovina, B&H." Bosnian Journal of Basic Medical Sciences 4, no. 4 (November 20, 2004): 63–65. http://dx.doi.org/10.17305/bjbms.2004.3364.
Full textAbstract:
In Federation of Bosnia and Herzegovina during 2002 a total of 67 cases of endometrial cancer (ICD 10th Revision Code C54) were registered among female population older then 15 years (1 per 10,000 population). Nine women were diagnosed with non specific malignant uteri neoplasia (C55)--without clarifying if that was cervix or corpus uteri located cancer, but assumption is that these cancers are actually endometrial cancer. Majority of cases are older then 50 years, 48 of them (71.6%), while 29 (28.4%) are from 15 to 49 years old. During 2000 about 189,000 new endometrial cancer cases were reported with 44,700 endometrial cancer deaths in the World. In this paper we presented geographical distribution of cases registered in FB&H, as well as leading risk factors, protective factors and prevention and possibilities for screening methods.
2
Mathur, Prashant, Krishnan Sathishkumar, Meesha Chaturvedi, Priyanka Das, Kondalli Lakshminarayana Sudarshan, Stephen Santhappan, Vinodh Nallasamy, Anish John, Sandeep Narasimhan, and Francis Selvaraj Roselind. "Cancer Statistics, 2020: Report From National Cancer Registry Programme, India." JCO Global Oncology, no. 6 (September 2020): 1063–75. http://dx.doi.org/10.1200/go.20.00122.
Full textAbstract:
PURPOSE The systematic collection of data on cancer is being performed by various population-based cancer registries (PBCRs) and hospital-based cancer registries (HBCRs) across India under the National Cancer Registry Programme–National Centre for Disease Informatics and Research of Indian Council of Medical Research since 1982. METHODS This study examined the cancer incidence, patterns, trends, projections, and mortality from 28 PBCRs and also the stage at presentation and type of treatment of patients with cancer from 58 HBCRs (N = 667,666) from the pooled analysis for the composite period 2012-2016. Time trends in cancer incidence rate were generated as annual percent change from 16 PBCRs (those with a minimum of 10 years of continuous good data available) using Joinpoint regression. RESULTS Aizawl district (269.4) and Papumpare district (219.8) had the highest age-adjusted incidence rates among males and females, respectively. The projected number of patients with cancer in India is 1,392,179 for the year 2020, and the common 5 leading sites are breast, lung, mouth, cervix uteri, and tongue. Trends in cancer incidence rate showed an increase in all sites of cancer in both sexes and were high in Kamrup urban (annual percent change, 3.8%; P < .05). The majority of the patients with cancer were diagnosed at the locally advanced stage for breast (57.0%), cervix uteri (60.0%), head and neck (66.6%), and stomach (50.8%) cancer, whereas in lung cancer, distant metastasis was predominant among males (44.0%) and females (47.6%). CONCLUSION This study provides a framework for assessing the status and trends of cancer in India. It shall guide appropriate support for action to strengthen efforts to improve cancer prevention and control to achieve the national noncommunicable disease targets and the sustainable development goals.
3
Zulfa, Lathifah Dzakiyyah, Dessyani Salim, and Abigail Tirza Silalahi. "Role of Tomato (Solanum lycopersicum) in Management and Prevention of Four Most Common Cancer in Indonesia." SCRIPTA SCORE Scientific Medical Journal 3, no. 2 (February 28, 2022): 186–91. http://dx.doi.org/10.32734/scripta.v3i2.5522.
Full textAbstract:
Introduction: The rate of new cancer cases in Indonesia is very high. With various risk factors, cancer becomes easier to attack individuals, but that does not mean these factors cannot be changed. One of the modifiable risk factors of cancer is diet from food. Objective: This review aims to investigate the role of chemical compound in tomato (S. lycopersicum) in management and prevention of breast, cervix uteri, lung, and liver cancer. Method: Method for writing this review is by searching for literature published in 2012 - 2020 was carried out to prove the effect of tomatoes on cancer incidence through in vitro, in vivo, and clinical studies. Results: Lycopene in tomatoes has been shown to withstand the cell cycle, inhibit NF-кB, and affect enzymes that produce toxic metabolites, thus preventing the development of various types of cancer. Other active compound such as carotenoid lutein can act as cytotoxic agents by increasing p53 phosphorylation and suppressing the expression of anti-apoptotic genes in breast cancer cells. Interaction between tomatine or tomatidine (another compound in tomatoes) with EGFR will prevent the development or metastasis of non-small cell lung carcinoma. Conclusion: These facts can be concluded that tomato (with various active compound in it) consumption potentially strong in preventing breast, cervix uteri, lung, and liver cancer. Further research should clarify the recommended tomato active compound level for daily consumption and its long-term side effect. Keywords: cancer, diet, Solanum lycopersicum Pendahuluan: Tingkat kasus baru kanker di Indonesia sangatlah tinggi. Terdapat 65.858 kasus baru kanker payudara pada 2020. Dengan berbagai macam faktor risiko, kanker menjadi lebih mudah menyerang individu, namun bukan berarti faktor tersebut tidak dapat diubah. Salah satu faktor risiko yang dapat dimodifikasi adalah diet. Tujuan: Ulasan ini bertujuan untuk membahas bagaimana konsumsi tomat dapat mengurangi risiko terkena kanker maupun memperbaiki prognosis penderita kanker. Metode: Metode penulisan ulasan ini adalah mencari literatur yang dipublikasi selama 2016 – 2021 secara daring dilakukan untuk membuktikan pengaruh tomat terhadap kejadian kanker baik secara in vivo, in vitro, serta penelitian klinis. Hasil: Lycopene yang terkandung pada tomat terbukti menahan siklus sel, menginhibisi NF- B, dan menekan efek enzim yang memproduksi metabolit beracun sehingga bermanfaat dalam mencegah perkembangan berbagai jenis kanker. Bahan aktif lain seperti karotenoid lutein mampu bertindak sebagai agen sitotoksik yang meningkatkan fosforilasi p53 dan menekan ekspresi gen anti – apoptotic pada sel kanker payudara. Interaksi tomatine dan tomatidine (kandungan lain pada tomat) dengan EGFR akan mencegah perkembangan maupun metastasis non-small cell lung carcinoma. Kesimpulan: Beberapa fakta tersebut dapat disimpulkan bahwa konsumsi tomat berpotensi mencegah kanker payudara, serviks uteri, paru – paru, dan hepar. Penelitian selanjutnya perlu membuktikan berapa rekomendasi banyaknya konsumsi tomat harian. Kata Kunci: diet, kanker, tomat
4
Moreira, Rita De Cássia Rocha, Ludmilla Oliveira Souza, Manoela De Assis Silva Carvalho, and Scheila Conceição Sacramento Saldanha. "Perfil epidemiológico do câncer de colo uterino no município de feira de santana, Bahia, Brasil." Revista de Enfermagem UFPE on line 3, no. 4 (September 19, 2009): 998. http://dx.doi.org/10.5205/reuol.581-3802-1-rv.0304200926.
Full textAbstract:
Objective: to determine the cervical cancer epidemiological profile in Feira de Santana city, from 2000 to 2004. Methods: documental research, quantitative methods, descriptive, whose data collection were in annual reports issued by the Municipal Secretariat of Health through the Information System in Cancer of the Uterine Cervix (SISCOLO). The collection instrument was a form consolidated. Descriptive analysis was conducted using statistical tests, calculating the incidence, relative frequency and mortality rates by age. The results are presented in tables. Results: regards to Cervical Intra-epithelial Neoplasia I (CIN I) the age group between 20-39 years old had the greatest number of cases, but in relation to CIN II the age group between 20-39 years old not presented cases in 2004. In CIN III there was an increase in the percentage distribution in the age group between 20-39 years old, there was a decrease in women between 40-59 years old and over 60 years old there were cases only occurred in 2002. The hospital morbidity predominated in the age group between 40-59 years. The absolute frequency shows decrease in the number of cases of hospitalization. Deaths by cervical cancer were predominant in the age group over 60 years old. Conclusion: to know cervical cancer epidemiological variables is fundamental because it makes possible to draw actions which contribute to the women’s health promotion. Descriptors: cancer; cervix uteri; prevention; epidemiology.
5
Momenimovahed, Zohre, and Hamid Salehiniya. "Incidence, mortality and risk factors of cervical cancer in the world." Biomedical Research and Therapy 4, no. 12 (December 8, 2017): 1795. http://dx.doi.org/10.15419/bmrat.v4i12.386.
Full textAbstract:
Background: Cervical cancer imposes a huge global burden. To date, various studies have been conducted on the risk factors associated with cervical cancer. The aim of this study was to investigate the incidence, mortality, and geographical distribution of cervical cancer and its risk factors in the world.
Methods: A literature search was conducted using PubMed, Web of sciences, Scopus, and Google Scholar to search for studies published between 2000 and 2017. The keywords used included cervical cancer, cervix uteri cancer, risk factor, incidence, mortality, and a combination of these terms.
Results: The results of this study showed that the incidence of cervical cancer varies considerably between developed and developing countries. The findings of this study demonstrated that several factors including sexually transmitted infections, reproductive factors, hormonal influences, genetics and host factors are responsible for the incidence of cervical cancer.
Conclusion: The results of this review study suggested that combination of biological, economic and health factors contributes to the incidence of cervical cancer. A large proportion cervical cancer can be prevented by prevention programs, lifestyle enhancement, smoking cessation, and timely and effective treatment of pre-cancerous lesions.
6
Rees, Margaret, Roberto Angioli, Robert L. Coleman, Rosalind M. Glasspool, Francesco Plotti, Tommaso Simoncini, and Corrado Terranova. "European Menopause and Andropause Society (EMAS) and International Gynecologic Cancer Society (IGCS) position statement on managing the menopause after gynecological cancer: focus on menopausal symptoms and osteoporosis." International Journal of Gynecologic Cancer 30, no. 4 (February 11, 2020): 428–33. http://dx.doi.org/10.1136/ijgc-2020-001217.
Full textAbstract:
Worldwide, it is estimated that about 1.3 million new gynecological cancer cases are diagnosed each year. For 2018, the predicted annual totals were cervix uteri 569 847, corpus uteri 382 069, ovary 295 414, vulva 44 235, and vagina 17 600. Treatments include hysterectomy with or without bilateral salpingo-oophorectomy, radiotherapy, and chemotherapy. These can result in loss of ovarian function and, in women under the age of 45 years, early menopause. The aim of this position statement is to set out an individualized approach to the management, with or without menopausal hormone therapy, of menopausal symptoms and the prevention and treatment of osteoporosis in women with gynecological cancer. Our methods comprised a literature review and consensus of expert opinion. The limited data suggest that women with low-grade, early-stage endometrial cancer may consider systemic or topical estrogens. However, menopausal hormone therapy may stimulate tumor growth in patients with more advanced disease, and non-hormonal approaches are recommended. Uterine sarcomas may be hormone dependent, and therefore estrogen and progesterone receptor testing should be undertaken to guide decisions as to whether menopausal hormone therapy or non-hormonal strategies should be used. The limited evidence available suggests that menopausal hormone therapy, either systemic or topical, does not appear to be associated with harm and does not decrease overall or disease-free survival in women with non-serous epithelial ovarian cancer and germ cell tumors. Caution is required with both systemic and topical menopausal hormone therapy in women with serous and granulosa cell tumors because of their hormone dependence, and non-hormonal options are recommended as initial therapy. There is no evidence to contraindicate the use of systemic or topical menopausal hormone therapy by women with cervical, vaginal, or vulvar cancer, as these tumors are not considered to be hormone dependent.
7
Kim, Jinhee, Donghwan Lee, Kyung-Bok Son, and SeungJin Bae. "The Burden of Cervical Cancer in Korea: A Population-Based Study." International Journal of Environmental Research and Public Health 17, no. 17 (August 30, 2020): 6308. http://dx.doi.org/10.3390/ijerph17176308.
Full textAbstract:
This study used the Korean National Health Insurance (NHI) claims database from 2011 to 2017 to estimate the incidence and the incidence-based cost of cervical cancer and carcinoma in situ of cervix uteri (CIS) in Korea. The primary outcome was the direct medical cost per patient not diagnosed with cervical cancer (C53) or CIS (D06) 2 years prior to the index date in the first year after diagnosis. A regression analysis was conducted to adjust for relevant covariates. The incidence of cervical cancer tended to decrease from 2013 to 2016, while that of CIS increased. In particular, the incidence rate of CIS in women in their 20 s and 30 s increased by 56.8% and 28.4%, respectively, from 2013 to 2016. The incidence-based cost of cervical cancer and CIS was USD 13,058 and USD 2695 in 2016, respectively, which increased from 2013. Multivariate regression analysis suggested that age was the most influential variable of the cost in both patient groups, and the cost was highest in those aged over 60, i.e., the medical cost was significantly lower in younger women than their older counterparts. These findings suggest that targeting younger women in cervical cancer prevention is a reasonable option from both economic and public health perspectives.
8
Demissie, Birhanu Wondimeneh, Gedion Asnake Azeze, Netsanet Abera Asseffa, Eyasu Alem Lake, Befekadu Bekele Besha, Kelemu Abebe Gelaw, Taklu Marama Mokonnon, Natnael Atnafu Gebeyehu, and Mohammed Suleiman Obsa. "Communities’ perceptions towards cervical cancer and its screening in Wolaita zone, southern Ethiopia: A qualitative study." PLOS ONE 17, no. 1 (January 7, 2022): e0262142. http://dx.doi.org/10.1371/journal.pone.0262142.
Full textAbstract:
Background Cervical cancer is a malignant neoplasm from cells originating in the cervix uteri. Any woman who is sexually active is at risk of getting HPV. Women in sub-Saharan Africa region have higher chance of developing the disease. There are nearly 26 million Ethiopian women who are over the age of 15 and believed to be at risk of getting HPV. Regrettably, Ethiopian women typically present for cervical cancer care at a late stage in the disease, where treatment is most ineffective. Objectives To explore communities’ perceptions of cervical cancer and screening among women in Wolaita zone, southern Ethiopia. Methods A qualitative research using focused group discussions and in-depth interviews was used to explore communities’ perceptions of cervical cancer and screening among women in Wolaita zone, southern Ethiopia from March 2018-November 2019. The study participants were men, women and communities who were residents of the study settings and were not health professionals. All focused group discussions (FGDs) and key informant interviews were transcribed and entered into Microsoft Word and thematic content analysis was done. Results A total of fifty-nine participants participated in both FGD (three with men and six with women) and in-depth interviews (IDIs). Most participants have not heard about cervical cancer but know cancer in general. Participants mentioned that the disease usually relates to many births and unprotected sexual intercourse but none mentioned HPV infection. Most of the participants perceive that cervical cancer is incurable and assume that it could be prevented but they think they are not vulnerable to the disease and screening is not necessary. Conclusion This study indicates that rural communities in the zone had limited knowledge about cervical cancer and even less about risk factors, screening, treatment and prevention. There is a great need for cancer education and prevention in Ethiopia.
9
Badar, F., and N. Anwar. "SP3-28 Is vaccination against the human papillomavirus for prevention of the cervix uteri cancer indicated in Pakistan where there is no Pap smear cervical cancer screening program-a public health perspective?" Journal of Epidemiology & Community Health 65, Suppl 1 (August 1, 2011): A416. http://dx.doi.org/10.1136/jech.2011.142976o.28.
Full text
10
Hussain, Syed Md Akram. "Comprehensive update on cancer scenario of Bangladesh." South Asian Journal of Cancer 02, no. 04 (October 2013): 279–84. http://dx.doi.org/10.4103/2278-330x.119901.
Full textAbstract:
AbstractBangladesh, at 142 million people, is the ninth most populous country in the world. There are 13 to 15 lakh cancer patients in Bangladesh, with about two lakh patients newly diagnosed with cancer each year. As an overview, lung cancer and mouth-oropharynx cancer rank as the top two prevalent cancers in males. Other types of cancers are esophagus cancer and stomach cancer. In women, cancer cervix uteri and breast cancer are most prevalent. Other cancer types, which affect women, are mouth and oropharynx cancer, lung cancer, and esophagus cancer. There are around 150 qualified clinical oncologists and 16 pediatric oncologists working in the different parts of the country. Regular cancer treatment is available in 19 hospitals and 465 hospital beds are attached as indoor or day care facilities for chemotherapy in the oncology/radiotherapy departments. There are about 15 linear accelerators, 12 Co-60 teletherapy and 12 brachytherapy units currently available. Approximately, 56 cancer chemotherapeutic agents are obtainable in Bangladesh. Research facilities are available at tertiary care centers and a few multi country collaborative research activities are ongoing. Bangladesh has a unique National Cancer Control Strategy and Plan of Action 2009-2015 formulated with the assistance of WHO with an objective to develop and implement continuum of cancer care through a comprehensive cancer control programe. Preventive measures taken to reduce the incidence of cancer include reduced tobacco smoking, change of dietary habit and reduced food adulteration, ensuring reproductive hygiene, increased physical activity, and reduced occupational hazard. Awareness buildup and media campaign are going on by organizing the general people, opinion leaders of the society, and boy and girl scout. Training of general physicians on cancer warning signs and setup of early cancer detection centers at each medical college and district levels are ongoing. Beside these, some other major cancer programs have taken place for early detection of breast, cervical and oral cancer by Bangladesh Government and NGOs such as ICDDR'B, BRAC, Ahsania Mission Cancer Hospital, BSMMU, Bangladesh Cancer Society, Ashic Foundation, Amader Gram, AK Khan Healthcare Trust, CANSUP, Oncology club etc. Piloting of cervical cancer vaccination has recently been completed. Improving the cancer scenario overnight is not an easy task but policy makers may become interested and push this agenda forward, if the huge health impact and economic loss caused by cancer become evident to them. Besides, Bangladesh has accepted reduction of cancer morbidity and mortality targets set by United Nations and World Health Organization as a part of global non-communicable disease prevention agreement.
11
Olkov, I. G., I. N. Kononova, N. K. Grishina, and Yu E. Dobrokhotova. "EPIDEMIOLOGICAL FEATURES OF PAPILLOMAVIRUS INFECTIONS AND CERVICAL CANCER IN THE REPUBLIC OF BASHKORTOSTAN AND THE KALININGRAD REGION." Problems of Social Hygiene, Public Health and History of Medicine 30, no. 5 (December 15, 2022): 788–94. http://dx.doi.org/10.32687/0869-866x-2022-30-5-788-794.
Full textAbstract:
In the context of improving cancer prevention programs, it becomes relevant to justify the introduction of regional HPV cervical cancer screening programs based on a study of the prevalence of human papillomavirus infection and cervical cancer.Aim: to identify the main patterns of the prevalence of human papillomavirus infection and cervical cancer in Bashkortostan and the Kaliningrad region for the scientific substantiation of the criteria for the adoption of regional screening programs.A prospective analytical cohort single-stage observational examination of 3428 women of the Republic of Bashkortostan and 1246 women of the Kaliningrad region was carried out, as well as a retrospective observational analytical study of cervical cancer incidence in Bashkiria and the Kaliningrad region according to the official statistics from 2011 to 2020 compared to Russian indicators.In Bashkortostan and the Kaliningrad region, HPV DNA was detected in 48.7% and 54.2% of women of reproductive age, respectively, of which HPV of high oncogenic risk (HPV HR) was 51.7 ± 6.2%, and 23.4% were found to have PCM . In the Kaliningrad region, HPV DNA was detected in 47.2% of the women under study, HPV VR - 31.1%, in 25.5% accompanied by cervix uteri diseases. An increase in the incidence is noted in the Kaliningrad region by 38.6% over 10 years, with an annual increase of 3.8%. In Bashkortostan, the growth is demonstrated by 31.8% with an annual increase of 3%, which is significantly higher than in the Russian Federation (13.3%, р=0.001). For 10 years, the prevalence of cervical cancer has increased in the Kaliningrad region by 10.1%, with an average annual increase of 1.1%. In Bashkortostan, the prevalence of CSM increased by 4.7% with an annual increase of 0.3%.The high prevalence of HPV infection among women of reproductive age, the unfavorable dynamics of indicators of cervical HPV-associated oncopathology in remote regions of the Russian Federation (Bashkiria and the Kaliningrad region) is a scientifically based criterion for the reorganization of regional cervical screening programs. The implementation of Organized screening with primary HPV examination with mandatory separate genotyping of types 16 and 18 and the remaining 12 types of HPV HRC in a complex will enhance the effectiveness of ongoing preventive measures and meet international standards.
12
Aida, Yuka, Hiroko Fukushima, Hiroko Bando, Eiichi Ishikawa, Ayumi Shikama, and Ikuo Sekine. "Characteristics of Cancers in Adolescents and Young Adults Compared with Those in Adults in Their 60s: A Single-Center Experience." Oncology 100, no. 3 (2022): 140–47. http://dx.doi.org/10.1159/000520291.
Full textAbstract:
<b><i>Introduction:</i></b> Cancer is one of the main causes of death among adolescents and young adults (AYAs) aged 15–39 years. The improvement in overall 5-year survival in AYA cancer patients was far below than that of adult cancer patients. The purpose of this study was to clarify the features of cancer in AYAs by comparing them with those of controls. <b><i>Methods:</i></b> Patients in the cancer registry of the University of Tsukuba Hospital between 2007 and 2017 (median age, 65 years) were included in this study. We used patients between the ages of 64 and 66 years as controls. We then obtained the age at diagnosis, sex, primary site, and pathological type. <b><i>Results:</i></b> Among 27,281 cancer patients in the registry between 2007 and 2017, 1,947 (7.1%) patients were categorized into the AYA group, and 2,354 into the control group. Among men in the AYA group, central nervous system (CNS) tumors accounted for 22.7% of all cancers, followed by germ cell tumors, 22.5%, and hematopoietic malignancies, 12.5%. Among women in the AYA group, cervical cancer accounted for 35.9% of all cancers, followed by breast cancer, 14.6%, and CNS tumors, 11.6%. The proportion of specific cancer types relative to all cancers in the CNS, thyroid, adrenal glands, germ cells, cervix uteri, hematopoietic tissues, and sarcomas was higher in the AYA group than that in the control group. <b><i>Conclusion:</i></b> The present results for AYAs were in sharp contrast to those for adult cancers and may be related to different modes of pathogenesis in AYAs. The identification of high-risk groups of these tumors in the AYA generation is crucial for prevention and early detection and will be a major topic for future research. While most of adult cancers are treated independently by each medical department, AYA cancers need to be treated in collaboration with experts from several departments. It is desirable to address the issues involved in applying treatments established for adult cancers to AYA cancers on a cancer-by-cancer basis.
13
Vasconcelos, Lívia Cristina, Déborah Santos Bueno, Jéssica Sundare Mendonça Silva, Rafaela Ferreira Dias Rios, Raquel Aparecida Pessoa, Rosilaine Freitas Moreira, and Heuler Souza Andrade. "Conhecimento de Mulheres a Respeito do Exame Papanicolau." UNICIÊNCIAS 21, no. 2 (November 6, 2017): 105. http://dx.doi.org/10.17921/1415-5141.2017v21n2p105-109.
Full textAbstract:
O câncer do colo de útero - CCU é considerado um problema de saúde pública mundial, com cerca de 530 mil novos casos por ano e 270 mil mortes em todo o mundo. O objetivo deste estudo foi descrever o conhecimento de mulheres pertencentes a um município do interior de Minas Gerais a respeito da prevenção CCU, por meio do exame Papanicolau. Trata-se de pesquisa descritiva, de abordagem quantitativa realizada em Carmo da Mata, MG, em 2015. A amostra foi composta por 93 mulheres cadastradas nas ESF do município, na faixa etária entre 25 e 64 anos. A coleta de dados foi realizada por meio de um formulário aplicado às participantes. Os dados foram analisados e descritos de forma a identificar os objetivos do estudo. A média de idade das participantes foi de 39 anos. A maioria, 65 (69,9%) têm mais de 8 anos de estudo, são casadas ou vivem em união estável. A maioria (96,7%) relatou ter realizado o Papanicolau no último ano. Quanto ao conhecimento sobre o exame, 78 (83,8%) afirmaram ter conhecido através de profissionais de saúde. No que diz respeito ao conhecimento dos fatores de risco para o câncer de colo uterino, 43 (46,2%) tinham conhecimento correto sobre o tema. Percebeu-se que as mulheres do município estudado têm conhecimento significativo em relação ao exame Papanicolau. A utilização do serviço de saúde para prevenção do CCU e o grau de escolaridade da maioria influencia, positivamente, na percepção da importância dessa prática.Palavras-chave: Colo do Útero. Teste de Papanicolau. Saúde da Mulher.AbstractCervical cancer - CCU, is considered a worldwide public health problem, with nearly 530,000 new cases per year and 270,000 deaths worldwide. The aim of this study was to describe the knowledge of women belonging to a city in the interior of Minas Gerais regarding CCU prevention through Pap smears. It is a descriptive research with a quantitative approach carried out in Carmo da Mata, MG, in 2015. The sample consisted of 93 women registered in the municipality of FHS, aged between 25 and 64 years. Data collection was carried out through a questionnaire applied to the participants. Data were analyzed and described in order to identify the goals of the study. The mean age of participants was 39 years. Most, 65 (69.9%) have more than 8 years of schooling, they are married or in stable relationships. Most (96.7%) reported having performed the Pap test last year. Regarding knowledge about the examination, 78 (83.8%) claimed to have known throughhealth professionals. Regarding knowledge of risk factors for cervical cancer, 43 (46.2%) had correct knowledge on the subject. It is noticed that the women of the city studied have significant knowledge regarding Pap smears. The use of health services for the prevention of cervical cancer and the level of education of most positively influence the perception of the importance of this practice.Keywords: Cervix Uteri. Papanicolau Test. Women’s Health.
14
Hamester, Letícia, and Vania C. Dezoti Micheletti. "COBERTURA DO EXAME CITOPATOLÓGICO EM UMA UNIDADE DE ESTRATÉGIA SAÚDE DA FAMÍLIA." Enfermagem em Foco 7, no. 3/4 (February 7, 2017): 27–30. http://dx.doi.org/10.21675/2357-707x.2016.v7.n3/4.911.
Full textAbstract:
Objetivos: avaliar o fluxo assistencial do programa de prevenção do câncer de colo de útero de uma unidade de Estratégia Saúde da Família. Metodologia: estudo descritivo transversal, com uma amostra de 1031 mulheres, cadastradas em uma unidade de saúde do município de Sapucaia do Sul-RS. A coleta de dados ocorreu entre 2012 e 2015, em fichas de cadastro do SUS e livro de registros de exames citopatológicos e inseridos em planilha eletrônica. A análise, segundo estatística descritiva, foi feita no software Excel® 2010. Resultados: 1031 mulheres tinham idade média de 43,17 anos. Dessas, em 64,5%, não havia registro de realização do exame preventivo do câncer uterino no período dos três anos de intervalo preconizados para a realização do exame. Conclusão: a cobertura do exame citopatológico está muito aquém do preconizado, sendo evidente a necessidade de aprimoramento das ações de rastreamento do câncer uterino.Descritores: Colo do Útero; Programas de Rastreamento; Teste de PapanicolauCOVERAGE OF THE PAPANICOLAOU TEST IN AN UNIT OF THE BRAZILIAN’S FAMILY HEALTH STRATEGYObjectives: evaluate the assistance flow of the cancer prevention program for cervical a unit of the Family Health Strategy, a health program of the Brazilian government, Methods: Descriptive cross-sectional study with a sample of 1,031 women registered at the health care unit in Sapucaia do Sul, southern of Brazil.. Data were collected from registration forms of the Brazilian Unified Health System, and record books of Papanicolaou tests from 2012 to 2015, and data was entered into spreadsheet . The analysis, according to descriptive statistics, was made in Excel 2010 software. . Results: They shown that mean age was 43.17 years for the 1,031 women under study. Of these, 64.5% did not undergo preventive exams for uterine cancer throughout the period of the 3-year interval recommended for women to undergo the exam. Conclusion: The coverage of the Papanicolaou test is much lower than recommended, with an evident need to improve screening for uterine cancer.Descriptors: Cervix Uteri; Mass Screening; Papanicolaou Test.COBERTURA DE LA PRUEBA DE PAPANICOLAOU EN UNA UNIDAD DE LA ESTRATÉGIA DE SALUD DE LA FAMILIAObjetivos: evaluar el flujo de la asistencia del programa de prevención del câncer del cáncer de cuello uterino adoptado por una unidad de la Estrategia de Salud de la Familia, un programa de salud del gobierno brasileño.. Métodos: Estudio descriptivo transversal con una muestra de 1.031 mujeres registradas en la unidad de salud en el municipio de Sapucaia do Sul, sur de Brasil. La recolección de datos ocurrió entre 2012 y 2015, en fichas de catastro del Sistema Único de Salud y libros de registro de pruebas de Papanicolaou y los datos introducidos en la hoja de cálculo. El análisis, de acuerdo con la estadística descriptiva, se hizo en el software Excel 2010. Resultados: Las 1.031 mujeres tenían edad media de 43,17 años. De estas, el 64,5% no habían realizado el examen preventivo de cáncer uterino en el período de los tres años de intervalo preconizados para la realización del examen. Conclusión: La cobertura de la prueba de Papanicolaou está muy por debajo del recomendado, siendo evidente la necesidad de perfeccionamiento de las acciones de tamizaje de cáncer uterino.Descriptores: Cuello del Útero; Tamizaje Masivo; Prueba de Papanicolaou.
15
Georgieva, S., P. Stefanova, and M. Kamburova. "Unsatisfactory effectiveness of preventive programs for oncogynecological diseases in Bulgaria." European Journal of Public Health 29, Supplement_4 (November 1, 2019). http://dx.doi.org/10.1093/eurpub/ckz186.201.
Full textAbstract:
Abstract Background Incidence rate and mortality of breast cancer and cancer of the cervix uteri in Bulgaria are higher in comparison with most countries of European Union (EU). Moreover, during the last three decades they have been increasing, even doubled for cervix cancer, although in developed countries there are proven effective prevention programs. The aim of the study is to explore how these programs are being implemented in Bulgaria and what caused their unsatisfactory results. Methods Data were collected by documents review and direct individual self-administered questionnaire among 186 women aged 30-69 concerning types and regularity of preventive activities. Results National Health Insurance Fund in Bulgaria defines as mandatory and finances a regular check-up annually for health insured people over 18 years of age. Mammography, as a screening of a breast cancer, was included in regular check-up package from the year 2011, once at every two years, for women aged 50-69. Papanicolau test for cancer of the cervix uteri wasn’t provided in the preventive package until the year 2017 when it was included only for women who complete 30 years of age in the current calendar year with intended regularity once at every two years. Women from other age groups currently are not covered with preventive examination for cervical cancer or they should pay for it which restricts accessibility and affordability of prevention activities. Study results indicates that every fifth of the investigated women have never had a prophylactic examination for breast cancer and cervical cancer. In addition, 69.4% of those who have such examination did not comply with the recommended regularity. Conclusions Screening programs against breast cancer and cancer of the cervix uteri are consistent with the recommendations of the oncology research societies but they being applied relatively soon in Bulgaria and some age groups are out of their coverage which decreases their effectiveness. Key messages Incidence rate and mortality of breast cancer and cancer of the cervix uteri in Bulgaria are higher than in most countries of European Union although there are proven effective prevention programs. Screening programs against breast cancer and cervical cancer are not effective because of their low accessibility and affordability and because they don’t comply with the recommended regularity.
16
O Al-Shamsi, Humaid. "The Burden of Gynecologic Cancers in the UAE." Journal of Oncology Research Review & Reports, August 31, 2021, 1–6. http://dx.doi.org/10.47363/jonrr/2021(2)143.
Full textAbstract:
There is limited published data about gynecological cancers in the UAE. The latest cancer registry data published in 2020 for the 2017 reports a total of 7% (301/4299 ) out of the total cases of all cancer among the UAE population. The most diagnosed gynecologic cancers were uterine, cervix uteri and ovarian cancer, which ranked 5th, 6th, and 8th, respectively among all female malignant cancers in the UAE. There were 111 cases of uterus cancer, which accounted for 4.93% of all cancer cases among females, diagnosed in 2017. Due to various well-structured programs in the UAE for cervical cancer prevention, including implementation of HPV vaccination for females, aged 15-26 years and screening with a pap test for women 25-65 years, regardless of their HPV vaccination status. The rate of carcinoma in situ of cervix uteri in the UAE has declined by over 50% (from 81 cases in 2015 to 38 cases in 2017). There were 70 cases of ovarian cancer, accounted for 3.11% of all cancer cases among females, diagnosed in 2017. The highest number of ovarian cancer cases has been reported in the age group of 50-54. The malignant neoplasm of cervix uteri makes up to 1.9% of the total deaths (ranked 6th), caused by cancer in the UAE population, in 2017. Currently, the gynecology cancer research in the UAE is very limited. There is a need for initiation of gynecology specific working groups to facilitate the research in this area with focus on prevention, early diagnosis, and screening specific to the UAE population.
17
Dhaouadi, S., A. Cherif, M. Osman, and M. Hsairi. "Cancer incidence trend in northern tunisia: 1994-2009." European Journal of Public Health 29, Supplement_4 (November 1, 2019). http://dx.doi.org/10.1093/eurpub/ckz186.650.
Full textAbstract:
Abstract Background Cancer is a major public health problem in Tunisia. The objectives of this study were to describe the epidemiological pattern of cancer for all and main cancer sites in Northern Tunisia during the period 2007-2009 and to analyze it’s incidence trend between 1994 and 2009. Methods Cancer registry of Northern Tunisia was the source of data for the identification of patients for this study. This registry notify, since 1994, all cases of malignant tumor in people living in the District of Tunis, Nabeul, Zaghouan, Bizerte (North East) Beja, Jendouba, Kef and Siliana (North West). Cases were codified using the third version of International Classification of Diseases for Oncology. Demographic data were provided by the National Statistical Institute. Incidence trend analysis was achieved by using JoinPoint Software. Results During the period 2007-2009, the age-standardised incidence rate of all sites combined was 149.2/100 000 person-years and 112.3/100 000 person-years respectively among males and females. The sex ratio was 1.26. The mean age at diagnosis was 58.28±16.77 years. The most common sites for males were: lung, bladder, prostate and colorectal; while for females, they were breast, colorectal, thyroid and cervix uteri. Local stage at diagnosis was observed in 37.7% of cases. The highest incidence rates were observed in the District of Tunis and in the governorates of North East. The trend incidence cancer of all sites combined during the period from 1994 to 2009 was significantly risen except for stomach cancer among males and cervix uteri among females with annual percent changes of -2.5% and of -4.1% respectively. Conclusions Despite the existence of a national cancer strategy in Tunisia, many barriers affect the implementation of interventions; while the trend cancer incidence continues to rise particularly in males. Strengthening prevention strategy of this scourge is strongly recommended. Key messages Cancer is a major public health in world and in Tunisia. Prevention must be applied to reduce the incidence of cancer.
18
Rosa, Luciana Martins da, Maria Eduarda Hames, Mirella Dias, Gisele Martins Miranda, Camila Beltrame Bagio, Maristela Jeci dos Santos, and Luciana Puchalski Kalinke. "Epidemiological profile of women with gynecological cancer in brachytherapy: a cross-sectional study." Revista Brasileira de Enfermagem 74, no. 5 (2021). http://dx.doi.org/10.1590/0034-7167-2020-0695.
Full textAbstract:
ABSTRACT Objective: to analyze the sociodemographic and clinical profile of women with gynecological cancer in brachytherapy. Method: a cross-sectional study including records of 1,930 visits of women in brachytherapy assisted between 2006-2016 in Santa Catarina (Brazil). Collection was performed in 2019, in an institutional bank, submitted to frequency measurements, chi-square test, 95% confidence intervals, significance level of 0.05. Results: women aged 40-59 years (47.2%), white (93.3%); with elementary school (65%); cervical cancer (78.5%); stages II-III (73.3%) figured prominently. In the comparison of staging proportions in the topography variable, a higher proportion of malignant neoplasm of cervix uteri unspecified in the grouped III-IV staging (84.6%). Conclusion: the profile analysis shows the need for screening and health education for prevention and/or early detection of gynecological cancers and training of nurses specialized in radiotherapy to care for women’s health.
19
Luo, Zheng, Yuan He, Guifen Ma, Yang Deng, Yichen Chen, Yi Zhou, Xiaoyun Xu, Xiaopan Li, and Yan Du. "Years of life lost due to premature death and their trends in people with malignant neoplasm of female genital organs in Shanghai, China during 1995–2018: a population based study." BMC Public Health 20, no. 1 (October 1, 2020). http://dx.doi.org/10.1186/s12889-020-09593-6.
Full textAbstract:
Abstract Background The increasing aging population has been posing a significant challenge to disease burden in developing countries. In particular, the contribution of population aging to and long term changes of disease burden of malignant neoplasm of female genital organs (MNFGO) have not been quantitatively demonstrated. Methods Data were collected from the Shanghai Vital Statistics System of Pudong New Area (PNA). Crude mortality rate (CMR), age-standardized mortality rate by Segi’s world standard population (ASMRW), and years of life lost (YLL) of MNFGO as the underlying cause of death in age and pathology types from 1995 to 2018 were calculated. The joinpoint regression was used to estimate the trends of those rates by identifying the annual percent changes (APCs), and the decomposition method was used to calculate the increased rates and the contribution resulting from demographic and non-demographic factors. Results From 1995 to 2018, a total of 2869 MNFGO-specific deaths were reported in PNA, accounting for 0.64% of the total deaths. The CMR and ASMRW of MNFGO were 9.23/105 person-years and 4.80/105 person-years, respectively. Ovary cancer was the most common cause of MNFGO death, accounting for 43.9% (1260/2869) of all MNFGO death. Other common causes of MNFGO death included cervix uteri cancer, uterus unspecified cancer, and corpus uteri cancer. With the increase of age, the mortality rate of MNFGO in residents had shown an upward trend ([APC (95%CI) = 3.46 (2.74, 4.18), P < 0.001)] for each five-year age group from 0 to 4 to 85+ years. From 1995 to 2018, YLL of MNFGO in Shanghai PNA was 42,152.82 years, and the rate of YLL was 135.56 /105. The top three MNFGO types in YLLs were ovary cancer, cervix uteri cancer and uterus unspecified cancer. Demographic factors contributed significantly to the upward trends of CMR, ASMRW, and YLL rates of MNFGO. Conclusion With aggravated population aging in Shanghai, MNFGO is and will continue to be a serious threat to women’s health. More precise and effective prevention strategies are needed to target high risk population, to achieve efficient health resource allocation and to improve women’s health in particular.
20
Kulothungan, Vaitheeswaran, Krishnan Sathishkumar, Sravya Leburu, Thilagavathi Ramamoorthy, Santhappan Stephen, Dharmappa Basavarajappa, Nifty Tomy, Rohith Mohan, Geetha R. Menon, and Prashant Mathur. "Burden of cancers in India - estimates of cancer crude incidence, YLLs, YLDs and DALYs for 2021 and 2025 based on National Cancer Registry Program." BMC Cancer 22, no. 1 (May 11, 2022). http://dx.doi.org/10.1186/s12885-022-09578-1.
Full textAbstract:
Abstract Background Cancer is the major cause of morbidity and mortality worldwide. The cancer burden varies within the regions of India posing great challenges in its prevention and control. The national burden assessment remains as a task which relies on statistical models in many developing countries, including India, due to cancer not being a notifiable disease. This study quantifies the cancer burden in India for 2016, adjusted mortality to incidence (AMI) ratio and projections for 2021 and 2025 from the National Cancer Registry Program (NCRP) and other publicly available data sources. Methods Primary data on cancer incidence and mortality between 2012 and 2016 from 28 Population Based Cancer Registries (PBCRs), all-cause mortality from Sample Registration Systems (SRS) 2012–16, lifetables and disability weight from World Health Organization (WHO), the population from Census of India and cancer prevalence using the WHO-DisMod-II tool were used for this study. The AMI ratio was estimated using the Markov Chain Monte Carlo method from longitudinal NCRP-PBCR data (2001–16). The burden was quantified at national and sub-national levels as crude incidence, mortality, Years of Life Lost (YLLs), Years Lived with Disability (YLDs) and Disability Adjusted Life Years (DALYs). The projections for the years 2021 and 2025 were done by the negative binomial regression model using STATA. Results The projected cancer burden in India for 2021 was 26.7 million DALYsAMI and expected to increase to 29.8 million in 2025. The highest burden was in the north (2408 DALYsAMI per 100,000) and northeastern (2177 DALYsAMI per 100,000) regions of the country and higher among males. More than 40% of the total cancer burden was contributed by the seven leading cancer sites — lung (10.6%), breast (10.5%), oesophagus (5.8%), mouth (5.7%), stomach (5.2%), liver (4.6%), and cervix uteri (4.3%). Conclusions This study demonstrates the use of reliable data sources and DisMod-II tools that adhere to the international standard for assessment of national and sub-national cancer burden. A wide heterogeneity in leading cancer sites was observed within India by age and sex. The results also highlight the need to focus on non-leading sites of cancer by age and sex. These findings can guide policymakers to plan focused approaches towards monitoring efforts on cancer prevention and control. The study simplifies the methodology used for arriving at the burden estimates and thus, encourages researchers across the world to take up similar assessments with the available data.